Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin α1β1 and α2β1-p38 MAPK signaling

Soichiro Ibaragi, Tsuyoshi Shimo, Nur Mohammad Monsur Hassan, Sachiko Isowa, Naito Kurio, Hiroki Mandai, Shinichi Kodama, Akira Sasaki

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Breast cancer cells frequently metastasize to the skeleton and produce and secrete proteinases, such as matrix metalloproteinase-13 (MMP-13), which promote destruction of the bone matrix. However, the mechanism of MMP-13 expression induced in areas of bone metastasis is unknown. Here, the interaction between tumors and type I collagen in bone metastasis was investigated. Materials and Methods: A mouse model of bone metastasis was prepared by inoculating mice with suspensions of cells of the human metastatic breast cancer cell line MDA-MB-231 via the left cardiac ventricle. MMP-13 expression was examined by immunohistochemical, Western blot, and real-time RT-PCR analyses. Results: MMP-13 expression was highly up-regulated in MDA-MB-231 cells, and attachment of these cells to type I collagen and the induction of MMP-13 were down-regulated by treatment with integrin α1, α2 or β1 neutralizing antibodies. The attachment of MDA-MB-231 cells to type I collagen induced the activation of focal adhesion kinase (FAK) and p38 mitogen-activated protein kinase (MAPK). Inhibition of FAK and p38 MAPK down-regulated type I collagen-induced MMP-13 expression. Conclusion: Our study indicates that metastatic breast cancer cells in the bone microenvironment attached to type I collagen, which stimulated integrins α1β1 and α2β1, via FAK and p38 MAPK pathways, to induce MMP13 expression and further osteolysis.

Original languageEnglish
Pages (from-to)1307-1313
Number of pages7
JournalAnticancer Research
Volume31
Issue number4
Publication statusPublished - Apr 2011

Fingerprint

Matrix Metalloproteinase 13
Bone Neoplasms
p38 Mitogen-Activated Protein Kinases
Collagen Type I
Integrins
Focal Adhesion Protein-Tyrosine Kinases
Bone and Bones
Breast Neoplasms
Neoplasm Metastasis
Heart Ventricles
Osteolysis
Bone Matrix
Neutralizing Antibodies
Skeleton
Real-Time Polymerase Chain Reaction
Suspensions
Peptide Hydrolases
Western Blotting
Cell Line
Neoplasms

Keywords

  • Bone metastasis
  • Integrin
  • MAPK
  • MMP-13
  • Type I collagen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin α1β1 and α2β1-p38 MAPK signaling. / Ibaragi, Soichiro; Shimo, Tsuyoshi; Hassan, Nur Mohammad Monsur; Isowa, Sachiko; Kurio, Naito; Mandai, Hiroki; Kodama, Shinichi; Sasaki, Akira.

In: Anticancer Research, Vol. 31, No. 4, 04.2011, p. 1307-1313.

Research output: Contribution to journalArticle

Ibaragi, Soichiro ; Shimo, Tsuyoshi ; Hassan, Nur Mohammad Monsur ; Isowa, Sachiko ; Kurio, Naito ; Mandai, Hiroki ; Kodama, Shinichi ; Sasaki, Akira. / Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin α1β1 and α2β1-p38 MAPK signaling. In: Anticancer Research. 2011 ; Vol. 31, No. 4. pp. 1307-1313.
@article{3a4ac6e5713b411c85701d08c8d24fef,
title = "Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin α1β1 and α2β1-p38 MAPK signaling",
abstract = "Background: Breast cancer cells frequently metastasize to the skeleton and produce and secrete proteinases, such as matrix metalloproteinase-13 (MMP-13), which promote destruction of the bone matrix. However, the mechanism of MMP-13 expression induced in areas of bone metastasis is unknown. Here, the interaction between tumors and type I collagen in bone metastasis was investigated. Materials and Methods: A mouse model of bone metastasis was prepared by inoculating mice with suspensions of cells of the human metastatic breast cancer cell line MDA-MB-231 via the left cardiac ventricle. MMP-13 expression was examined by immunohistochemical, Western blot, and real-time RT-PCR analyses. Results: MMP-13 expression was highly up-regulated in MDA-MB-231 cells, and attachment of these cells to type I collagen and the induction of MMP-13 were down-regulated by treatment with integrin α1, α2 or β1 neutralizing antibodies. The attachment of MDA-MB-231 cells to type I collagen induced the activation of focal adhesion kinase (FAK) and p38 mitogen-activated protein kinase (MAPK). Inhibition of FAK and p38 MAPK down-regulated type I collagen-induced MMP-13 expression. Conclusion: Our study indicates that metastatic breast cancer cells in the bone microenvironment attached to type I collagen, which stimulated integrins α1β1 and α2β1, via FAK and p38 MAPK pathways, to induce MMP13 expression and further osteolysis.",
keywords = "Bone metastasis, Integrin, MAPK, MMP-13, Type I collagen",
author = "Soichiro Ibaragi and Tsuyoshi Shimo and Hassan, {Nur Mohammad Monsur} and Sachiko Isowa and Naito Kurio and Hiroki Mandai and Shinichi Kodama and Akira Sasaki",
year = "2011",
month = "4",
language = "English",
volume = "31",
pages = "1307--1313",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin α1β1 and α2β1-p38 MAPK signaling

AU - Ibaragi, Soichiro

AU - Shimo, Tsuyoshi

AU - Hassan, Nur Mohammad Monsur

AU - Isowa, Sachiko

AU - Kurio, Naito

AU - Mandai, Hiroki

AU - Kodama, Shinichi

AU - Sasaki, Akira

PY - 2011/4

Y1 - 2011/4

N2 - Background: Breast cancer cells frequently metastasize to the skeleton and produce and secrete proteinases, such as matrix metalloproteinase-13 (MMP-13), which promote destruction of the bone matrix. However, the mechanism of MMP-13 expression induced in areas of bone metastasis is unknown. Here, the interaction between tumors and type I collagen in bone metastasis was investigated. Materials and Methods: A mouse model of bone metastasis was prepared by inoculating mice with suspensions of cells of the human metastatic breast cancer cell line MDA-MB-231 via the left cardiac ventricle. MMP-13 expression was examined by immunohistochemical, Western blot, and real-time RT-PCR analyses. Results: MMP-13 expression was highly up-regulated in MDA-MB-231 cells, and attachment of these cells to type I collagen and the induction of MMP-13 were down-regulated by treatment with integrin α1, α2 or β1 neutralizing antibodies. The attachment of MDA-MB-231 cells to type I collagen induced the activation of focal adhesion kinase (FAK) and p38 mitogen-activated protein kinase (MAPK). Inhibition of FAK and p38 MAPK down-regulated type I collagen-induced MMP-13 expression. Conclusion: Our study indicates that metastatic breast cancer cells in the bone microenvironment attached to type I collagen, which stimulated integrins α1β1 and α2β1, via FAK and p38 MAPK pathways, to induce MMP13 expression and further osteolysis.

AB - Background: Breast cancer cells frequently metastasize to the skeleton and produce and secrete proteinases, such as matrix metalloproteinase-13 (MMP-13), which promote destruction of the bone matrix. However, the mechanism of MMP-13 expression induced in areas of bone metastasis is unknown. Here, the interaction between tumors and type I collagen in bone metastasis was investigated. Materials and Methods: A mouse model of bone metastasis was prepared by inoculating mice with suspensions of cells of the human metastatic breast cancer cell line MDA-MB-231 via the left cardiac ventricle. MMP-13 expression was examined by immunohistochemical, Western blot, and real-time RT-PCR analyses. Results: MMP-13 expression was highly up-regulated in MDA-MB-231 cells, and attachment of these cells to type I collagen and the induction of MMP-13 were down-regulated by treatment with integrin α1, α2 or β1 neutralizing antibodies. The attachment of MDA-MB-231 cells to type I collagen induced the activation of focal adhesion kinase (FAK) and p38 mitogen-activated protein kinase (MAPK). Inhibition of FAK and p38 MAPK down-regulated type I collagen-induced MMP-13 expression. Conclusion: Our study indicates that metastatic breast cancer cells in the bone microenvironment attached to type I collagen, which stimulated integrins α1β1 and α2β1, via FAK and p38 MAPK pathways, to induce MMP13 expression and further osteolysis.

KW - Bone metastasis

KW - Integrin

KW - MAPK

KW - MMP-13

KW - Type I collagen

UR - http://www.scopus.com/inward/record.url?scp=79956073397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956073397&partnerID=8YFLogxK

M3 - Article

C2 - 21508380

AN - SCOPUS:79956073397

VL - 31

SP - 1307

EP - 1313

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -